Targeting modulation of the choroid plexus blood-CSF barrier and CSF hypersecretion via lipid nanoparticle-mediated co-delivery of siRNA and resveratrol
Abstract Hydrocephalus is one of the most common neurological disorders, but pharmacotherapy options are currently lacking due to the complex pathogenesis. The blood-CSF barrier (BCSFB), consisting of choroid plexus (ChP) epithelial cells, is a crucial gate for the entry of peripheral immune cells a...
Saved in:
| Main Authors: | Qiguang Wang, Xue Xia, Huan Zhang, Yue Li, Lei Zhu, Yulong Shi, Yuzhao Tang, Jian Cheng, Xuhui Hui, Huile Gao |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Nature Communications |
| Online Access: | https://doi.org/10.1038/s41467-025-61543-1 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Blood-cerebrospinal fluid (CSF) barrier dysfunction means reduced CSF flow not barrier leakage - conclusions from CSF protein data
by: Hansotto REIBER -
Choroid plexus-mediated CSF secretion remains stable in aging rats via high and age-resistant metabolic activity
by: Sara D. Lolansen, et al.
Published: (2025-07-01) -
CHOROID PLEXUS CARCINOMA AND CHOROID PLEXUS PAPILLOMA; RARE CASES
by: Şule Çalışkan Kamış, et al.
Published: (2024-12-01) -
Dissection of blood–brain barrier dysfunction through CSF PDGFRβ and amyloid, tau, neuroinflammation, and synaptic CSF biomarkers in neurodegenerative disordersResearch in context
by: Agathe Vrillon, et al.
Published: (2025-05-01) -
New CSF biomarkers on the block
by: Charlotte E Teunissen, et al.
Published: (2016-09-01)